Longboard Pharmaceuticals
6 clinical trials · Sponsor
◉ Watch Longboard Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) (NCT06908226) | Longboard Pharmaceuticals | 2025-02-12 |
| A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) (NCT06719141) | Longboard Pharmaceuticals | 2024-11-11 |
| A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) (NCT06660394) | Longboard Pharmaceuticals | 2024-09-25 |
| Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy (NCT05626634) | Longboard Pharmaceuticals | 2022-11-08 |
| Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies (NCT05364021) | Longboard Pharmaceuticals | 2022-03-03 |
Track Longboard Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.